SOUTH SAN FRANCISCO, Calif., Oct. 16, 2023 (GLOBE NEWSWIRE) Pliant Therapeutics, Inc. (Nasdaq: PLRX), a clinical-stage biotechnology company and leader in the discovery and development of novel therapeutics for the treatment of fibrotic diseases, today announced the appointment of Ms. S. Mishima Gerhart as Chief Regulatory Officer. Ms. Gerhart will lead the Company’s regulatory and quality strategies and activities. “Mishima brings a dynamic set of drug development experiences including the d
/PRNewswire/ The "RNA Therapeutics Market and RNA Vaccines Market by Type of Modality, Type of Molecule, Therapeutic Areas, Route of Administration, Key.
DUBLIN (BUSINESS WIRE) The "Plasma Fractionation Market by Type of Company, Scale of Operation, Type of Plasma-derived Therapeutic Products Manufactured, Therapeutic Areas of Plasma-derived Products and Key Geographical Regions: Industry Trends and Global Forecasts, 2023-2035" report has been added to ResearchAndM.
/PRNewswire/ The Scleroderma Research Foundation (SRF), the nation s largest non-profit funder of scleroderma research, today announced that Boehringer.